Oncogenesis due to immunosuppressive agents (cytostatics) in (NZBxNZW) mice
Mitrou, P.S.; Fischer, M.; Mitrou, G.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1729-1731
1976
ISSN/ISBN: 0070-4067 PMID: 1030094 Document Number: 109311
Document emailed within 1 workday
Related Documents
Schuppli, R. 1970: Treatment of dermatologic lesions using immunosuppressive agents and cytostatics Münchener Medizinische Wochenschrift 112(12): 526-530Lagrue, G.; Bariéty, J. 1970: Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents) Münchener Medizinische Wochenschrift 112(12): 515-522
Ohtaki, S. 1978: Suppressive effects on simian virus 40-induced oncogenesis of several immunosuppressive agents and hormonal modifications applied during the latent period Cancer Research 38(12): 4698-4710
Greenwood, B.M.; Voller, A. 1970: Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice Clinical and Experimental Immunology 7(6): 793-803
Anderlik, P. 2001: Biological effects of microorganisms, their substances and immunosuppressive agents in mice Orvosi Hetilap 142(43): 2377-2380
Rivero, I.; Blythman, H.; Baez, J.R. 1977: Study on the addi;ive effect of thymectomy and immunosuppressive agents in adult mice Revista Clinica Espanola 147(5): 461-465
van der Nat, J.M.; Beijnen, J.H.; Driebergen, R.J.; Thart, L.A.; van Dijk, H.; Underberg, W.J.; Labadie, R.P. 1988: In vitro immunosuppressive activities of recently developed anthracycline cytostatics Anticancer Research 8(3): 489-493
Scherf, H.R.; Krüger, C.; Karsten, C. 1970: Studies in rats on immunosuppressive properties of cytostatics with special consideration of carcinogenic effect Arzneimittel-Forschung 20(10): 1467-1470
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E. 1991: Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice Transplantation Proceedings 23(1 Part 1): 270-271
Peterson, A.R.; Peterson, H.; Heidelberger, C. 1979: Oncogenesis, mutagenesis, DNA damage, and cytotoxicity in cultured mammalian cells treated with alkylating agents Cancer Research 39(1): 131-138
Schmitt, E.; Kröger, E.; Lakner, V.; Klinkmann, H.; Ratner, M.; Tomilina, N. 1979: Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(17): 465-471
Semont, H.; Hecquet, C.; Adolphe, M.; Deysson, G. 1982: Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice Experimental Hematology 10(9): 782-788
Sieklucka-Dziuba, M.; Saczonek, J.; Dziuba, J.; Kleinrok, Z. 1998: Central action of some cytostatics--methotrexate (MTX) and doxorubicin (DXR). II. the influence on the seizure activity and the learning and memory processes in mice Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 53: 81-88
Mertens, H.G. 1980: Immunosuppressive agents Die Medizinische Welt 31(40): 1440-1443
Sanchez-Fayos, J.; Outeirino, J.; Serrano, J.; Calabuig, M.T.; Paniagua, G. 1970: Immunosuppressive agents in hematology Minerva Medica 61(55): 3082-3098
Treleaven, J.G.; Barrett, A.J. 1990: Immunosuppressive agents in current use British Journal of Hospital Medicine 43(4): 256-264
Genazzani, E.; Periti, P. 1978: Pharmacology of immunosuppressive agents Minerva Medica 69(38): 2587-2604
Merlino, G. 1994: Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice Seminars in Cancer Biology 5(1): 13-20
Rogner, G. 1974: Thrombocyte function during the use of immunosuppressive agents Folia Haematologica 101(5): 792-799
Frei, P.C. 1973: Treatment of polyarthritis by immunosuppressive agents Schweizerische Medizinische Wochenschrift 103(33): 1159-1161